Henri Bogumil

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion.

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion.

Journal: The oncologist
Published: October 09, 2025

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica
Published: August 26, 2025

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Journal: Nature cancer
Published: July 26, 2025

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Journal: Neuro-oncology
Published: July 22, 2025

Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnostics.

Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnostics.

Journal: Acta neuropathologica communications
Published: July 11, 2025

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

Journal: Acta neuropathologica
Published: October 22, 2024

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors.

Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors.

Journal: Nature medicine
Published: March 28, 2024

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.

Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.

Journal: Acta neuropathologica
Published: August 17, 2023

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.

Journal: Acta neuropathologica
Published: January 04, 2023
Showing 1-9 of 9

Last Updated: 09/26/2026